Concepedia

Publication | Open Access

Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis

DOIFull Paper Access

145

Citations

34

References

2015

Year

Elias S. Sotirchos, Pavan Bhargava, Christopher Eckstein, Keith Van Haren, Moira Baynes, Achilles Ntranos, Anne R. Gocke, Lawrence Steinman, Ellen M. Mowry, Peter A. Calabresi
Neurology

Abstract

This study provides Class I evidence that cholecalciferol supplementation with 10,400 IU daily is safe and well-tolerated in patients with MS and exhibits in vivo pleiotropic immunomodulatory effects.

References

YearCitations

Page 1